PathAI
AI HealthcarePaid
AI-powered digital pathology platform that automates slide analysis, biomarker quantification, and drug development support for labs and biopharma.
0 upvotesadvanced
Compare PathAI vs Tempus AI
Both tools in AI Healthcare
Tempus AI
AI HealthcarePaid
Precision medicine platform using AI and genomics to power cancer diagnostics, clinical trial matching, and multimodal data insights for oncology and beyond.
0 upvotesadvanced
Add a third tool to compare
Search for an AI tool to add it to this comparison.
Pricing
Pricing Comparison
PathAI
Enterprise$Custom
Annual licensing, cloud infrastructure, algorithm modules
Biopharma$Custom
Companion diagnostic development, clinical trial services, data licensing
Tempus AI
Genomic Testing$Custom/test
Oncology, hereditary, pharmacogenomic, and MRD panels
Data Licensing$Custom
Multi-year Lens platform contracts for biopharma and research
Enterprise$Custom
Integrated health system and clinical copilot deployment
Features
Feature Comparison
PathAI
AISight Digital Pathology PlatformWhole Slide Image ManagementAI Tumor Detection AlgorithmsBiomarker Quantification (PD-L1, HER2)MASH AI Assist (FDA and EMA Qualified)Companion Diagnostic DevelopmentPrecision Pathology Network AccessPLUTO Foundation ModelExplore Biomarker Discovery SuiteLIS IntegrationCase Management AutomationRemote Consultation and AnnotationGCP and GCLP Compliant Lab ServicesFDA-Cleared AISight Dx PlatformClinical Trial Patient StratificationReal-World Data MonetizationPathologist Network (450+ contributors)
Tempus AI
xT DNA Tumor SequencingxF Liquid Biopsy TestingxR RNA-Based TestingHereditary Cancer Risk TestingMinimal Residual Disease (MRD) MonitoringAI Clinical Copilot (Tempus One)Patient Cohort Builder (Lens Platform)Natural Language Cohort QueryBiomarker Discovery EngineClinical Trial Patient MatchingEHR-Integrated Genomic InsightsCare Gap Identification (Tempus Next)De-identified Data LicensingPharmacogenomic TestingCardiology AI ApplicationsRadiology AI IntegrationMultimodal Data Library
Fit
Best For & Not For
PathAI
✅ Best For
✅Anatomic pathology laboratories at academic medical centers, reference labs, and health systems looking to digitize workflows and deploy AI-powered diagnostic algorithms. Biopharma companies developing companion diagnostics, conducting clinical trials, or seeking AI-assisted biomarker discovery using validated pathology datasets.
❌ Not For
❌Individual clinicians or small outpatient practices without pathology laboratory operations. Organizations seeking ambient documentation or clinical note generation rather than digital pathology image analysis and drug development tools.
Tempus AI
✅ Best For
✅Oncologists, precision medicine teams, and research coordinators at academic medical centers and large cancer programs who need comprehensive genomic profiling to guide treatment decisions. Biopharma companies and research organizations looking to license de-identified multimodal clinical data or access Tempus's Lens platform for biomarker discovery and clinical trial optimization.
❌ Not For
❌General practitioners or small practices without oncology focus who do not regularly order genomic testing. Organizations seeking ambient documentation, clinical note generation, or administrative AI tools rather than diagnostics and research data platforms.
Availability
Platform & Accessibility
PathAI
web-basedapi
Tempus AI
web-basedapi
Use & Audience
Tasks & Who It's For
Integrations
Integrations
PathAI
Other
Quest Diagnostics LISLabcorp LISPaigeVisiopharm
Tempus AI
Other
EpicOracle HealthAstraZenecaMerck
Use Cases
Real-world Use Cases
PathAI
1
A reference lab pathologist reviews 80 cases per day with AISight's AI-flagged priority queue, focusing attention on the highest-risk slides first and reducing average sign-out time by 35%.2
A biopharma data scientist uses PathAI's Explore biomarker discovery suite to identify a novel spatial biomarker in a pancreatic cancer dataset of 12,000 slides that predicts immunotherapy response, advancing a Phase 2 trial design.3
Labcorp deploys AISight Dx across its US pathology network after its expanded PathAI partnership, enabling digital workflows for case management, slide review, and AI-assisted annotation at scale.Tempus AI
1
Dr. Osei, a breast oncologist, orders Tempus xT sequencing on a newly diagnosed patient with triple-negative breast cancer and uses the AI report to identify a BRCA2 variant, immediately qualifying the patient for a PARP inhibitor trial and changing her treatment plan.2
A genomic counselor at a large cancer center uses Tempus's hereditary testing from Ambry Genetics to screen 50 at-risk patients per month for inherited cancer syndromes, enabling preventive interventions before cancer develops.3
A biopharma data scientist builds a precision cohort for an immuno-oncology trial using the Lens platform's natural language query, identifying 800 eligible patients in seconds from millions of de-identified records.Keep Exploring